Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Abbott_Laboratories
|
| gptkbp:focusesOn |
Point-of-care testing
|
| gptkbp:foundedBy |
gptkb:Abbott_Laboratories
|
| gptkbp:hasPart |
Genetic testing
Sustainability initiatives Collaborations with research institutions Software solutions Consumables Reagents Data management systems Allergy testing Research and development services Patient management systems Laboratory instruments Customer support services Corporate social responsibility programs Clinical decision support tools Diagnostic imaging products FreeStyle Libre Health information technology solutions Quality control products Telehealth solutions Regulatory compliance services Training and education services Therapeutic drug monitoring Participation in clinical trials Partnerships with healthcare providers ARCHITECT system Autoimmune testing Blood glucose monitoring systems Cardiac markers Chronic disease management tools Endocrine testing Gastrointestinal testing ID NOW Infectious disease panels Men's health tests Molecular diagnostics platform Nutritional testing Pediatric testing Point-of-care devices Rapid tests Respiratory testing Tumor markers Veritor system Women's health tests i-STAT system Alinity_system Panbio_tests |
| gptkbp:headquarters |
gptkb:Abbott_Park,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abbott Diagnostics
|
| gptkbp:industry |
Healthcare
|
| gptkbp:offers |
Hematology
Molecular diagnostics Immunoassays Clinical chemistry Infectious disease testing Cardiometabolic_testing |
| gptkbp:operatesIn |
Global market
|
| gptkbp:products |
Diagnostic tests
|
| gptkbp:specializesIn |
Medical devices
|